Home › NDC Lookup › RxCUI directory › RxCUI 308177

Amoxicillin 125 MG Chewable Tablet — RxCUI 308177

RxNorm drug concept · Semantic clinical drug
RxCUI 308177 Semantic clinical drug · SCD ● Current RxNorm concept 9 FDA products 17 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI308177
Official nameAmoxicillin 125 MG Chewable Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped9
Package NDCs mapped17
Reported Medicaid activity (SDUD)2,058,843 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Amoxicillin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It is an antibiotic for infections caused by susceptible bacteria. These include ear, nose and throat, chest, urinary tract and skin infections. In adults it is also used with othe...
  • Take it by mouth at the start of a meal, which helps limit stomach upset. Follow the schedule your prescriber gave you. Finish the full course even if you feel better, because stop...
  • Diarrhea, nausea, vomiting and mild rash are the most common. Call your doctor if a rash spreads, if you have severe or bloody diarrhea, or if your child has repeated vomiting an h...
  • What side effects are normal, and when should I call?
📖 Read our full Amoxicillin guide →

🕸️ Concept Web — How Amoxicillin 125 MG Chewable Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Amoxicillin 125 MG Chewable Tablet RxCUI 308177

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Amoxicillin 723
  2. Dose forms 8

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Amoxicillin Chewable Tablet 370577
    • Amoxicillin Chewable Product 1295175
    • Amoxicillin Oral Product 1152900
    • Amoxicillin Pill 1152901
    • Chewable Tablet 91058
    • Chewable Product 1294716
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Amoxicillin 125 MG 315367

Showing up to 8 concepts per family — 10 of 10 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Amoxicillin 125 MG SCDC · 315367
  • Amoxicillin Chewable Tablet SCDF · 370577
  • Amoxicillin Chewable Product SCDG · 1295175
  • Amoxicillin Oral Product SCDG · 1152900
  • Amoxicillin Pill SCDG · 1152901

📦 FDA Products & Package NDCs

9 products · 17 package NDCs
17 package NDCs map to RxCUI 308177 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00093-2263-01 100 TABLET, FILM COATED in 1 BOTTLE (0093-2263-01) Amoxicillin Teva Pharmaceuticals USA, Inc. 2000-11-21
00093-2264-01 100 TABLET, FILM COATED in 1 BOTTLE (0093-2264-01) Amoxicillin Teva Pharmaceuticals USA, Inc. 2000-09-26
00093-2267-01 100 TABLET, CHEWABLE in 1 BOTTLE (0093-2267-01) Amoxicillin Teva Pharmaceuticals USA, Inc. 1995-10-01
00093-2268-01 100 TABLET, CHEWABLE in 1 BOTTLE (0093-2268-01) Amoxicillin Teva Pharmaceuticals USA, Inc. 1993-01-01
00093-3107-01 100 CAPSULE in 1 BOTTLE (0093-3107-01) Amoxicillin Teva Pharmaceuticals USA, Inc. 1990-09-30
00093-3107-05 500 CAPSULE in 1 BOTTLE (0093-3107-05) Amoxicillin Teva Pharmaceuticals USA, Inc. 1990-09-30
00093-3109-05 500 CAPSULE in 1 BOTTLE (0093-3109-05) Amoxicillin Teva Pharmaceuticals USA, Inc. 1990-09-30
00093-3109-53 50 CAPSULE in 1 BOTTLE (0093-3109-53) Amoxicillin Teva Pharmaceuticals USA, Inc. 1990-09-30
00093-4155-73 100 mL in 1 BOTTLE (0093-4155-73) Amoxicillin Teva Pharmaceuticals USA, Inc. 1990-09-30
00093-4155-79 80 mL in 1 BOTTLE (0093-4155-79) Amoxicillin Teva Pharmaceuticals USA, Inc. 1990-09-30
00093-4155-80 150 mL in 1 BOTTLE (0093-4155-80) Amoxicillin Teva Pharmaceuticals USA, Inc. 1990-09-30
00093-4160-73 100 mL in 1 BOTTLE (0093-4160-73) Amoxicillin Teva Pharmaceuticals USA, Inc. 2003-04-02
00093-4160-76 50 mL in 1 BOTTLE (0093-4160-76) Amoxicillin Teva Pharmaceuticals USA, Inc. 2003-07-01
00093-4160-78 75 mL in 1 BOTTLE (0093-4160-78) Amoxicillin Teva Pharmaceuticals USA, Inc. 2003-07-01
00093-4161-73 100 mL in 1 BOTTLE (0093-4161-73) Amoxicillin Teva Pharmaceuticals USA, Inc. 2003-02-26
00093-4161-76 50 mL in 1 BOTTLE (0093-4161-76) Amoxicillin Teva Pharmaceuticals USA, Inc. 2003-07-01
00093-4161-78 75 mL in 1 BOTTLE (0093-4161-78) Amoxicillin Teva Pharmaceuticals USA, Inc. 2003-07-01
Observed labelers: Teva Pharmaceuticals USA, Inc. (17) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.